Objectives: Novel D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) modified lipid nanocapsules (LNC) were prepared with the aim of improving the effectiveness of simvastatin (SIM) in hepatocellular carcinoma (HCC). The present study, therefore, sought to investigate the effect of size-optimized SIM-loaded LNC on epithelial-to-mesenchymal transition (EMT) in HCC, providing insights on the implication of phosphatase and tensin homolog (PTEN)/protein kinase B (AKT) axis.
Methods: Two optimized SIM-loaded LNCs with particle sizes 25 nm (SIM-LNC25) and 50 nm (SIM-LNC50) were prepared and biodistribution studies were performed. The anticancer effect of the prepared LNC was evaluated both and . The anti-migratory potential and EMT suppression through PTEN/AKT axis modulation were also explored.
Results: SIM-LNC50 was superior to SIM-LNC25 in both and experiments, as evidenced by cytotoxicity assays, tumor histopathology, and enhanced apoptosis. SIM-LNC50 also alleviated the migratory potential of HCC cells. Moreover, EMT markers implied a transition of tumor cells toward the epithelial rather than the mesenchymal phenotype both and . PTEN/AKT axis modulation was also evident with SIM-LNC50.
Conclusion: The present study, therefore, suggests the efficacy of the 50 nm particles in SIM-loaded LNC in HCC by targeting EMT via modulating the PTEN/AKT signaling axis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/17425247.2023.2216451 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A versatile tumor-targeted drug-delivery system based on IR808-modified nanoparticles, its co-loading with PTX and R848 and its extraordinary antitumor efficacy.
Nanoscale
November 2024
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China.
Nearly all antitumor drugs can benefit greatly from effective tumor-targeted delivery for improved therapeutic efficacy and reduced toxic side effects. However, the vast majority of tumor-targeting ligands can only target specific tumor cells that highly express the corresponding receptors and thus are only applicable to limited tumor types. Heptamethine cyanines with medium cyclohexene and medium Cl atoms, such as IR780 and IR808, have shown an unusual ability to indiscriminately accumulate into virtually all tumor types.
View Article and Find Full Text PDFQuality by Design-Steered Development of Stealth Liposomal Formulation of Everolimus: A Systematic Optimization and Evaluation.
Curr Drug Metab
November 2024
Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga 142001, Punjab, India.
Background: Everolimus is a drug approved for the treatment of breast cancer with HR+ and advanced breast cancer reoccurring in postmenopausal women. The oral administration of EVE has been observed to have low oral bioavailability and severe epithelial cutaneous events that include rashes and lip ulceration followed by mouth ulceration after oral administration.
Aim: The present research aimed to enhance the bioavailability by loading the EVE into a stealth liposomal formulation (S-EVE-LIPO) intended for intravenous administration.
Enhanced anti-inflammatory activity of chlorogenic acid via folic acid-TPGS-modified liposomes encapsulation: characterization and evaluation on colitis mice.
Front Pharmacol
August 2024
College of Food Science and Engineering, Jiangxi Agricultural University, Nanchang, China.
Introduction: Chlorogenic acid (CGA) has been identified to possess salient anti-inflammatory, antioxidant, and anticancer attributes. However, its application is limited by its instability and low bioavailability. Liposomes have been considered effective pharmaceutical delivery vehicles due to their ability to continuously release loaded drugs, improve drug stability, and display good biocompatibility.
View Article and Find Full Text PDFFabrication and characterization of TPGS-modified chlorogenic acid liposomes and its bioavailability in rats.
RSC Adv
August 2024
College of Food Science and Engineer, Jiangxi Agricultural University Nanchang 330045 China
Article Synopsis
- Chlorogenic acid (CGA) has notable health benefits but suffers from instability and poor absorption in the body, limiting its effectiveness.
- Researchers developed CGA-TPGS-LP, a TPGS-modified liposome that encapsulates CGA, showing improvements in stability and bioavailability.
- Testing in rats revealed that this formulation enhances the absorption of CGA by 1.52 times and maintains effective concentrations of its metabolites, highlighting its potential for clinical applications.
siRNA-loaded folic acid-modified TPGS alleviate MASH targeting ER stress sensor XBP1 and reprogramming macrophages.
Int J Biol Sci
August 2024
Department of Pharmacy, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China.
Macrophages show high plasticity and play a vital role in the progression of metabolic dysfunction-associated steatohepatitis (MASH). X-box binding protein 1 (XBP1), a key sensor of the unfolded protein response, can modulate macrophage-mediated pro-inflammatory responses in the pathogenesis of MASH. However, how XBP1 influences macrophage plasticity and promotes MASH progression remains unclear.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!